| 产品名称: | LDK378 |
| Cas No.: | 1032900-25-6 |
| 规格:: | 克 |
| 价格: | 1元/ |
| 发布日期:: | 2015-11-03 |
| CAS NO. 1032900-25-6 英文品名 LDK378 中文品名 色瑞替尼 分子式 C28H36ClN5O3S 分子量 558.14 规格/纯度 98% 供应能力 can supply large quantity in kgs scale 别名 LDK 378; LDK-378; Ceritinib 产品简述 LDK378 is a highly selective inhibitor of an important cancer target, anaplastic lymphoma kinase (ALK) . 详细说明 LDK378 is a highly selective inhibitor of an important cancer target, anaplastic lymphoma kinase (ALK) . LDK378 has received Breakthrough Therapy designation by the US Food and Drug Administration (FDA) for the treatment of patients with anaplastic lymphoma kinase positive (ALK+) metastatic non-small cell lung cancer (NSCLC) who had progressed during treatment with, or were intolerant to, crizotinib. Approximately 3-8% of patients with NSCLC have the ALK gene mutation [1]. There are limited tr |
|